| Authors: |
Giersing B; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: giersingb@who.int., Mo AX; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: moa@niaid.nih.gov., Hwang A; Angela Hwang Consulting, PO Box 6601, Albany, California 94706, USA. Electronic address: angela@ahwang.net., Baqar S; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: baqars@niaid.nih.gov., Earle K; Vaccine Development, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: kristen.earle@gatesfoundation.org., Ford A; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: aford@niaid.nih.gov., Deal C; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: cdeal@niaid.nih.gov., Dull P; Vaccine Development, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: peter.dull@gatesfoundation.org., Friede M; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: friedem@who.int., Hall BF; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: lhall@niaid.nih.gov. |
